| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1112434916 |
| P356 | DOI | 10.1038/S41598-018-36179-5 |
| P932 | PMC publication ID | 6395627 |
| P698 | PubMed publication ID | 30816123 |
| P2093 | author name string | Balvinder Singh | |
| Javed N Agrewala | |||
| Gurkirat Kaur | |||
| Deepyan Chatterjee | |||
| Shilpa Muradia | |||
| P2860 | cites work | Structure-based discovery of opioid analgesics with reduced side effects | Q26331003 |
| Computational methods in drug discovery | Q26997089 | ||
| Structure-based virtual screening for drug discovery: a problem-centric review | Q27022502 | ||
| PubChem Substance and Compound databases | Q27942588 | ||
| Virtual Screening Approaches towards the Discovery of Toll-Like Receptor Modulators | Q28068082 | ||
| Virtual screening strategies in drug discovery | Q28253252 | ||
| Automated docking screens: a feasibility study | Q28256939 | ||
| Function-specific virtual screening for GPCR ligands using a combined scoring method | Q28276613 | ||
| Virtual screening: an endless staircase? | Q28278411 | ||
| Toll-Like Receptor 7 Agonists: Chemical Feature Based Pharmacophore Identification and Molecular Docking Studies | Q28488415 | ||
| ChemMine tools: an online service for analyzing and clustering small molecules | Q28530229 | ||
| Exploring the composition of protein-ligand binding sites on a large scale | Q28535327 | ||
| Structure-based virtual screening and characterization of a novel IL-6 antagonistic compound from synthetic compound database | Q28817043 | ||
| Comparative protein structure modeling using Modeller | Q29615142 | ||
| Protein pockets: inventory, shape, and comparison | Q30494235 | ||
| Parallel solution- and solid-phase synthesis of spirohydantoin derivatives as neurokinin-1 receptor ligands | Q30843486 | ||
| Selection criteria for drug-like compounds | Q30901599 | ||
| LINGO, an efficient holographic text based method to calculate biophysical properties and intermolecular similarities | Q30986370 | ||
| Recent advances in computer-aided drug design | Q33443633 | ||
| A statistical framework to evaluate virtual screening | Q33484416 | ||
| Current trends in ligand-based virtual screening: molecular representations, data mining methods, new application areas, and performance evaluation | Q33525328 | ||
| RFDT: A Rotation Forest-based Predictor for Predicting Drug-Target Interactions using Drug Structure and Protein Sequence Information | Q51066062 | ||
| A Virtual Screening Approach Applied to the Search for Trypanothione Reductase Inhibitors | Q52259530 | ||
| Structure Based Virtual Screening Studies to Identify Novel Potential Compounds for GPR142 and Their Relative Dynamic Analysis for Study of Type 2 Diabetes | Q52371257 | ||
| Practices in Molecular Docking and Structure-Based Virtual Screening | Q54118796 | ||
| Changing Trends in Computational Drug Repositioning. | Q55717464 | ||
| Pharmacologic Modulation of Human Immunity in the Era of Immuno-oncology: Something Old, Something New | Q57178646 | ||
| Cutting edge: a small molecule antagonist of LFA-1-mediated cell adhesion | Q73160656 | ||
| Progress and Hurdles for Follow-on Biologics | Q87253146 | ||
| Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays | Q88951624 | ||
| Cheminformatics-aided discovery of small-molecule Protein-Protein Interaction (PPI) dual inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL). | Q33584492 | ||
| State-of-the-art in ligand-based virtual screening | Q33829354 | ||
| Freely Accessible Databases of Commercial Compounds For High- Throughput Virtual Screenings | Q34165439 | ||
| Structure-based and ligand-based virtual screening of novel methyltransferase inhibitors of the dengue virus | Q34175884 | ||
| Small-molecule inhibitors of protein-protein interactions: progressing toward the reality | Q34263719 | ||
| The process of structure-based drug design | Q34266765 | ||
| Structure-based virtual screening of small-molecule antagonists of platelet integrin αIIbβ3 that do not prime the receptor to bind ligand | Q34380036 | ||
| Targeting ICAM-1/LFA-1 interaction for controlling autoimmune diseases: designing peptide and small molecule inhibitors | Q35121998 | ||
| CASTp: Computed Atlas of Surface Topography of proteins | Q35207451 | ||
| Structure-based virtual screening for drug discovery: principles, applications and recent advances. | Q35282223 | ||
| Regulatory and clinical considerations for biosimilar oncology drugs | Q35505833 | ||
| Receptor-based virtual screening protocol for drug discovery. | Q35653355 | ||
| Protein-protein interactions as targets for small-molecule therapeutics in cancer | Q37114139 | ||
| Inhibitors targeting the LFA-1/ICAM-1 cell-adhesion interaction: design and mechanism of action | Q37264826 | ||
| Recent advances in structure-based virtual screening of G-protein coupled receptors | Q37416441 | ||
| Essential considerations for using protein-ligand structures in drug discovery. | Q38021298 | ||
| Virtual screening strategies in drug discovery: a critical review. | Q38104785 | ||
| Developing oncology biosimilars: an essential approach for the future | Q38165447 | ||
| Biosimilars: a cure to the U.S. health care cost conundrum? | Q38254679 | ||
| Role of computer-aided drug design in modern drug discovery. | Q38553677 | ||
| Docking and Virtual Screening Strategies for GPCR Drug Discovery | Q38564024 | ||
| Drug-target interaction prediction: databases, web servers and computational models | Q38568763 | ||
| Computational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads | Q38751263 | ||
| HOMCOS: a server to predict interacting protein pairs and interacting sites by homology modeling of complex structures | Q39785046 | ||
| Bolstering Immunity through Pattern Recognition Receptors: A Unique Approach to Control Tuberculosis | Q40086314 | ||
| Best of both worlds: on the complementarity of ligand-based and structure-based virtual screening | Q41093798 | ||
| SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules | Q42318665 | ||
| CPHmodels-3.0--remote homology modeling using structure-guided sequence profiles | Q42682817 | ||
| A Computational-Based Method for Predicting Drug-Target Interactions by Using Stacked Autoencoder Deep Neural Network | Q47690935 | ||
| Discovery of a Small-Molecule Inhibitor of Interleukin 15: Pharmacophore-Based Virtual Screening and Hit Optimization | Q48210895 | ||
| Discovery of Novel Ligands for TNF-α and TNF Receptor-1 through Structure-Based Virtual Screening and Biological Assay. | Q48258862 | ||
| Toll-like receptor 2 antagonists identified through virtual screening and experimental validation. | Q48344368 | ||
| Rational design of novel TLR4 ligands by in silico screening and their functional and structural characterization in vitro. | Q50171368 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 3092 | |
| P577 | publication date | 2019-02-28 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | ImmtorLig_DB: repertoire of virtually screened small molecules against immune receptors to bolster host immunity | |
| P478 | volume | 9 |
Search more.